Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Atlan-Gepner

Showing results (1-10 of 23) with videos related to

Pageof 3
Sort By:
Diabetes & Metabolism|August 12, 1999
[When and why should anti-GAD antibodies by looked for in the non-insulin-dependent diabetic patient?]C Atlan-Gepner, B Vialettes
Diabetes/Metabolism Reviews|December 1, 1993
Specific immunotherapy for the prevention of diabetes: theoretical and practical aspectsB Vialettes, C Atlan-Gepner, L Hermitte
Diabete & Metabolisme|January 1, 1994
[Outlook for the future in the treatment of diabetic retinopathy]B Vialettes, P Silvestre-Aillaud, C Atlan-Gepner
Journal of Autoimmunity|September 10, 1999
Constitutive impaired TCR/CD3-mediated activation of T cells in IDDM patients co-exist with normal co-stimulation pathwaysS Nervi, C Atlan-Gepner, C Fossat, et al.
Lancet (London, England)|August 26, 1998
A cyclophosphamide-induced autoimmune diabetesC Atlan-Gepner, R Bouabdallah, R Valero, et al.
Diabetes & Metabolism|January 7, 1998
Different TH2-TH1 balance in V beta 8 and V beta 6 subsets of splenocytes in NOD females in the early phase of diabetogenesisC Atlan-Gepner, L Hermitte, B Janand-Delenne, et al.
Diabete & Metabolisme|October 1, 1995
Dietary protection against diabetes in NOD mice: lack of a major change in the immune systemL Hermitte, C Atlan-Gepner, M J Payan, et al.
Autoimmunity|May 2, 2000
Disorganization of thymic medulla precedes evolution towards diabetes in female NOD miceC Atlan-Gepner, M Naspetti, R Valéro, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 9, 2000
Specific deficiency of p56lck expression in T lymphocytes from type 1 diabetic patientsS Nervi, C Atlan-Gepner, B Kahn-Perles, et al.
The British Journal of Nutrition|July 27, 2000
Dietary fat clearance in type V hyperlipoproteinaemia secondary to a rare variant of human apolipoprotein E: the apolipoprotein E3 (Arg 136-->Ser)B Vialettes, P Reynier, C Atlan-Gepner, et al.
Pageof 3

Showing results (1-10 of 23) with videos related to

Sort By:
Pageof 3
Diabetes & Metabolism|August 12, 1999
[When and why should anti-GAD antibodies by looked for in the non-insulin-dependent diabetic patient?]C Atlan-Gepner, B Vialettes
Diabetes/Metabolism Reviews|December 1, 1993
Specific immunotherapy for the prevention of diabetes: theoretical and practical aspectsB Vialettes, C Atlan-Gepner, L Hermitte
Diabete & Metabolisme|January 1, 1994
[Outlook for the future in the treatment of diabetic retinopathy]B Vialettes, P Silvestre-Aillaud, C Atlan-Gepner
Journal of Autoimmunity|September 10, 1999
Constitutive impaired TCR/CD3-mediated activation of T cells in IDDM patients co-exist with normal co-stimulation pathwaysS Nervi, C Atlan-Gepner, C Fossat, et al.
Lancet (London, England)|August 26, 1998
A cyclophosphamide-induced autoimmune diabetesC Atlan-Gepner, R Bouabdallah, R Valero, et al.
Diabetes & Metabolism|January 7, 1998
Different TH2-TH1 balance in V beta 8 and V beta 6 subsets of splenocytes in NOD females in the early phase of diabetogenesisC Atlan-Gepner, L Hermitte, B Janand-Delenne, et al.
Diabete & Metabolisme|October 1, 1995
Dietary protection against diabetes in NOD mice: lack of a major change in the immune systemL Hermitte, C Atlan-Gepner, M J Payan, et al.
Autoimmunity|May 2, 2000
Disorganization of thymic medulla precedes evolution towards diabetes in female NOD miceC Atlan-Gepner, M Naspetti, R Valéro, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 9, 2000
Specific deficiency of p56lck expression in T lymphocytes from type 1 diabetic patientsS Nervi, C Atlan-Gepner, B Kahn-Perles, et al.
The British Journal of Nutrition|July 27, 2000
Dietary fat clearance in type V hyperlipoproteinaemia secondary to a rare variant of human apolipoprotein E: the apolipoprotein E3 (Arg 136-->Ser)B Vialettes, P Reynier, C Atlan-Gepner, et al.
Pageof 3